Puma Biotechnology Stock Options
| PBYI Stock | USD 2.94 0.08 2.65% |
Puma Biotechnology's latest option contracts expiring on 2024-12-20 are carrying combined implied volatility of 2.88 with a put-to-call open interest ratio of 0.11 over 6 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-12-20. The total put volume is at 27.0, with calls trading at the volume of 27.0. This yields a 0.21 put-to-call volume ratio.
Open Interest Against 2024-12-20 Option Contracts
2024-12-20
The chart above shows Puma Biotechnology's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Puma Biotechnology's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Puma Biotechnology's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Puma Biotechnology
Analyzing Puma Biotechnology's in-the-money options over time can help investors to take a profitable long position in Puma Biotechnology regardless of its overall volatility. This is especially true when Puma Biotechnology's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Puma Biotechnology's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Puma Biotechnology's stock while costing only a fraction of its price.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
Puma Biotechnology In The Money Call Balance
When Puma Biotechnology's strike price is surpassing the current stock price, the option contract against Puma Biotechnology stock is said to be in the money. When it comes to buying Puma Biotechnology's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Puma Biotechnology are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Puma Current Options Market Mood
Puma Biotechnology's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Puma Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Puma Biotechnology's options investors are not very successful. Puma Biotechnology's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Puma contract
Base on the Rule 16, the options market is currently suggesting that Puma Biotechnology will have an average daily up or down price movement of about 0.18% per day over the life of the 2024-12-20 option contract. With Puma Biotechnology trading at USD 2.94, that is roughly USD 0.005292. If you think that the market is fully incorporating Puma Biotechnology's daily price movement you should consider buying Puma Biotechnology options at the current volatility level of 2.88%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Puma |
Purchasing Puma Biotechnology options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Puma calls. Remember, the seller must deliver Puma Biotechnology stock to the call owner when a call is exercised.
Puma Biotechnology Option Chain
When Puma Biotechnology's strike price is surpassing the current stock price, the option contract against Puma Biotechnology stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Puma Biotechnology's option chain is a display of a range of information that helps investors for ways to trade options on Puma. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Puma. It also shows strike prices and maturity days for a Puma Biotechnology against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | PBYI Option Call 20-12-2024 2 | 274 | 2024-12-20 | 0.4 - 0.65 | 0.5 | In |
Call | PBYI Option Call 20-12-2024 5 | 655 | 2024-12-20 | 0.0 - 0.05 | 0.05 | Out |
Call | PBYI Option Call 20-12-2024 7 | 619 | 2024-12-20 | 0.0 - 0.1 | 0.03 | Out |
Call | PBYI Option Call 20-12-2024 10 | 259 | 2024-12-20 | 0.0 - 0.05 | 0.03 | Out |
Put | PBYI Option Put 20-12-2024 2 | 196 | 2024-12-20 | 0.0 - 0.25 | 0.05 | Out |
Put | PBYI Option Put 20-12-2024 5 | 11 | 2024-12-20 | 2.4 - 2.8 | 2.2 | In |
Puma Biotechnology Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Puma Biotechnology Market Cap Over Time
Market Cap |
| Timeline |
Puma Total Stockholder Equity
Total Stockholder Equity |
|
Puma Biotechnology Corporate Management
| Jeffrey Ludwig | Chief Officer | Profile | |
| Alvin Pharmd | Chief Officer | Profile | |
| FRAPS BSc | Pharmacovigilance, Affairs | Profile | |
| Bo Chao | Senior Development | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.417 | Earnings Share 0.47 | Revenue Per Share 5.045 | Quarterly Revenue Growth 0.435 | Return On Assets 0.0973 |
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.